Abstract In order to reduce calories in foods and beverages, the food industry routinely uses non-nutritive sweeteners. Unfortunately, many are synthetically derived, and many consumers have a strong preference for natural sweeteners, irrespective of the safety data on synthetic non-nutritive sweeteners. Additionally, many non-nutritive sweeteners elicit aversive side tastes, such as bitter and metallic, in addition to sweetness. Bitterness thresholds of acesulfame-K (AceK) and saccharin are known to vary across bitter taste receptor polymorphisms in TAS2R31. Rebaudioside A (RebA) has been shown to activate hTAS2R4 and hTAS2R14 in vitro. Here, we examined the bitterness and sweetness perception of natural and synthetic non-nutritive sweeteners. In a follow-up to a previous gene association study, participants (n=122) who had been genotyped previously rated sweet, bitter, and metallic sensations from RebA, rebaudioside D (RebD), aspartame, sucrose, and gentiobiose in duplicate in a single session. For comparison, we also present sweet and bitter ratings of AceK collected in the original experiment for the same participants. At similar sweetness levels, aspartame elicited less bitterness than RebD, which was significantly less bitter than RebA. The bitterness of RebA and RebD showed wide variability across individuals, and bitterness ratings for these compounds were correlated. However, RebA and RebD bitterness did not covary with AceK bitterness. Likewise, single-nucleotide polymorphisms (SNPs) shown previously to explain the variation in the suprathreshold bitterness of AceK (rs3741845 in TAS2R9 and rs10772423 in TAS2R31) did not explain the variation in RebA and RebD bitterness. Because RebA activates hT2R4 and hT2R14, an SNP in TAS2R4 previously associated with variation in bitterness perception was included here; there are no known functional SNPs for TAS2R14. In the present data, a putatively functional SNP (rs2234001) in TAS2R4 did not explain the variation in RebA or RebD bitterness. Collectively, these data indicate that the bitterness of RebA and RebD cannot be predicted by AceK bitterness, reinforcing our view that bitterness is not a simple monolithic trait that is high or low in an individual. This also implies that consumers who reject AceK may not find RebA and RebD aversive, and vice versa. Finally, RebD may be a superior natural nonnutritive sweetener to RebA, as it elicits significantly less bitterness at similar levels of sweetness.
perennial shrub native to Paraguay and Brazil. The Guaraní Paraguayan Indians and Mestizos have used Stevia leaves for centuries to sweeten teas, beer, and tobacco (reviewed by Lewis 1992 ). The sweetness is elicited by diterpenic entkaurene glycosides, each exhibiting a steviol aglycone (13-hydroxykaur-16-en-18-oic acid) . The Joint FAO/WHO Expert Committee on Food Additives reported that 9 glycosides are found in Stevia leaves (JECFA 2010) ; however, since the publication of this report, an additional 26 glycosides have been identified (Ohta et al. 2010 ; for a comprehensive list, see Wölwer-Rieck 2012) . These glycosides differ greatly in concentration in the leaf and are also influenced by the plants' genotype and growing conditions. Typically, stevioside and RebA are the two most abundant glycosides (Ohta et al. 2010) . Currently, purified RebA, purified stevioside, and purified RebA/stevioside blends have a generally recognized as safe (GRAS) status in the USA, while whole leaf Stevia and crude Stevia extracts are not approved for use in foods. It is likely that additional purified steviol glycosides will be approved in the near future.
These glycosides differ in their sensory properties, as shown by DuBois et al. (1991) , Hellfritsch et al. (2012) , Phillips (1989) , and Schiffman et al. (1995a, b) . Although Stevia leaves and its glycoside extracts are known for their sweetness, many also elicit undesirable side tastes, including bitterness (DuBois et al. 1991; Hellfritsch et al. 2012; Schiffman et al. 1995b) .
The ability to detect bitterness from various bitter compounds differs greatly across individuals. Much of the variation can be explained by polymorphisms in bitter taste receptors (Dotson et al. 2012; Duffy et al. 2004 Duffy et al. , 2010 Feeney 2011; Hayes et al. 2011; Pronin et al. 2007; Roudnitzky et al. 2011; Wang et al. 2007 ). Additional variance can be attributed to age (Mennella et al. 2010 ) and fungiform papillae density (Bartoshuk et al. 1994; Duffy and Bartoshuk 2000) , as well as other factors (Tepper et al. 2003) . Specific to non-nutritive sweeteners, variation in bitter taste receptor genes can explain the differences in bitterness arising from these sweeteners. Kuhn et al. (2004) showed that saccharin and acesulfame-K (AceK) activate bitter taste receptors hT2R31 and hT2R43 (encoded by the TAS2R31 and TAS2R43 genes near chromosome 12p13.2) in vitro. Subsequently, Pronin et al. (2007) found that polymorphisms within TAS2R31, specifically the Arg35Trp allele, predicted bitterness perception of sampled saccharin in 55 subjects. Presumably, these single-nucleotide polymorphisms (SNPs) might also influence AceK bitterness, as earlier psychophysical evidence suggested that saccharin and AceK bitterness covary across individuals (Horne et al. 2002) . Roudnitzky et al. (2011) confirmed this, showing that the bitterness of saccharin and AceK is associated with several polymorphisms in TAS2R31, with the greatest variation explained by the Arg35Trp allele. Individuals who expressed Trp at position 35 perceived greater bitterness than those with an Arg at this residue. This finding was confirmed in vitro, where taste receptor cells expressing the Arg35 variant show little to no activation when exposed to saccharin or AceK (Roudnitzky et al. 2011) . They also identified eight additional SNPs that further modify the activation of TAS2R31 in varying amounts (D45H, M162L, Q127E, A226V, L237F, V240I, P276R, and W281C) (Roudnitzky et al. 2011) .
Elsewhere, Dotson et al. (2008) reported that the Ala187Val polymorphism in TAS2R9 (chromosome 12p13) influenced the activation of cells exposed to three pharmaceuticals commonly described as bitter: ofloxacin, procainamide, and pirenzepine. The Val187 allele was associated with limited to no activation, compared to the Ala187 allele. Data from our laboratory indicates that this SNP significantly predicts the bitterness from AceK . Unexpectedly, the pattern that was observed is the opposite of that seen in vitro by Dotson et al. (2008) for different stimuli; our data suggest that the Val197 allele is the high-function allele, at least with respect to AceK .
Recently, Hellfritsch et al. (2012) expressed all 25 bitter taste receptors in a cell culture and treated them with 1 mM stevioside. Two of these receptors, hT2R4 and hT2R14, were activated by stevioside. Subsequently, these two receptors were tested with seven additional glycosides (RebA, RebB, RebC, RebD, dulcoside A, steviolbioside, and rubusoside).
All of the steviol glycosides tested activated these receptors, except steviolbioside, which did not activate hT2R14, and RebD, which did not activate either receptor hT2R4 or hT2R14 (Hellfritsch et al. 2012 ). There are no polymorphisms reported to be functional at a behavioral level for TAS2R14, while published (Hayes et al. 2011 ) and unpublished reports (Alarcon et al. 2008) suggest that the Val96Leu allele in TAS2R4 may associate with differences in bitterness perception.
Few studies have compared bitterness and sweetness across multiple non-nutritive sweeteners (Kamerud and Delwiche 2007) . Here, we report the sweetness and bitterness intensity of two natural non-nutritive sweeteners (RebA and RebD), as well as two commonly used synthetic non-nutritive sweeteners (AceK and aspartame).
Multiple studies indicate that polymorphisms in bitter taste receptor genes (TAS2Rs) influence the perception of bitterness from synthetic sulfonyl amide sweeteners like saccharin and AceK. Likewise, anecdotal reports suggest that the bitterness from natural Stevia-derived sweeteners is not experienced universally. However, it remains unknown whether (a) the bitterness of natural Stevia-derived sweeteners, specifically RebA and RebD, covary with the bitterness of sulfonyl amide sweeteners across individuals and (b) whether variable bitterness in RebA and RebD might be explained by genetic polymorphisms in TAS2R genes. Here, we compare the sensory profiles of Stevia-derived glycosides, describe the variation in the bitterness of these stimuli across individuals, and explore whether this variability can be predicted by polymorphisms in genes previously implicated in the bitterness of other non-nutritive sweeteners (i.e., TAS2R9 and TAS2R31).
Materials and Methods

Overview
Here, we present data from a follow-up study to a larger project on the genetics of oral sensation (Project GIANT-CS; Allen et al. 2013; Byrnes and Hayes 2013) . Participants who had completed the main study and had been genotyped were invited to return to our laboratory to taste a variety of tastants not originally included in the main study, including multiple non-nutritive sweeteners and disaccharides. One hundred twenty-two participants returned to complete the follow-up study. The study was conducted in the Sensory Evaluation Center at the Pennsylvania State University in individual testing test booths under white light. After participants were re-consented in writing for the follow-up study, they participated in a 3-min training session in a multifunction space in our facility prior to entering the test booths. All procedures for the main project and follow-up study were approved by the Pennsylvania State University Institutional Review Board (protocol numbers #33176 and #40921). In isolated testing booths, participants rated bitter, sweet, and metallic sensations on a computerized general labeled magnitude scale (gLMS).
Participants
Participants were screened prior to the start of the main study. Eligibility criteria included: age between 18 and 45 years old, not pregnant or breastfeeding, nonsmoker (had not smoked in the last 30 days), no known defects of smell or taste, no lip, cheek, or tongue piercings, no history of any condition involving chronic pain, not currently taking any prescription pain medication, no reported history of choking or difficulty swallowing, and no history of thyroid disease.
Here, we report data from 122 participants (44 men), with a mean age 27.7±7.89 years. Self-reported race and ethnicity was collected based on criteria provided by the 1997 OMB Directive 15. This population is largely of European ancestry (n=88), with marginal representation from other ancestry, African (n=2) and Asian (n=21), with 9 individuals choosing to not disclose their ancestry.
Training Session
Participants were asked to rate sweetness, bitterness, and metallic on a gLMS. Due to potential confusion between bitter and metallic, a brief training session was implemented to provide individuals examples of these three taste qualities. After consent was obtained, participants went through a short 2-to 3-min training session from project staff individually or in small groups (no more than three to a group). Four 10-ml samples were presented labeled samples as exemplars of specific taste qualities: "sweet"=250 mM sucrose (Domino), "bitter"=0.05 mM quinine (SAFC), "bitter and sweet"=263 mM sucrose and 0.5 mM quinine, and "metallic"=1.0 mM FeSO 4 (J.T. Baker). The concentrations of the training samples were chosen to be similar to the test samples, eliciting sweet, bitter, mixture, and metallic (all well above the threshold values). The presentation order of the training stimuli was fixed (sweet, bitter, sweet and bitter, and metallic). At the start of the training session, participants were given a spit cup and a water cup. Participants were provided the following instructions: "This training session is to help familiarize you with the taste qualities you will be asked to rate in this study. The three qualities are sweetness, bitterness, and metallic." The researcher then provided instructions on how to taste the samples: "Put the whole sample in your mouth, swish for 3 s and spit it out. Then rinse with water." The samples were presented in a clear plastic medicine cup with the respective labels (sweet, bitter, sweet and bitter, and metallic). The researcher presented each sample one at a time and participants were told the taste quality(s). After tasting, participants were told that, if they experience this taste, they would rate the perceived intensity on the respective scale. A mixture of sucrose and quinine was provided to give an example of a sample that may have multiple taste qualities (sweet and bitter). Prior to entering the testing booths, participants were asked to rinse with water to remove any lingering sensations.
Psychophysical Scaling of Test Stimuli
Participants reported perceived intensity of the test stimuli by rating on a gLMS. The gLMS anchors are 0 ("no sensation") to 100 ("the strongest imaginable sensation of any kind"), with descriptors at 1.4 ("barely detectable"), 6 ("weak"), 17 ("moderate"), 35 ("strong"), and 51 ("very strong"). All participants had been trained to use the gLMS in the main study, and they were reoriented to the scale before the tasting test stimuli. This was done by asking participants to rate six imagined or remembered sensations on the gLMS. The orientation included both oral and non-oral items to promote ratings in the context of all modalities, not just taste . Data were collected using Compusense five, version 5.2 (Guelph, Ontario, Canada). We considered collecting bitter recognition thresholds (e.g., Hellfritsch et al. 2012 ), but we chose to focus on suprathreshold measures here because they are more relevant to food sensations and intake (e.g., Duffy et al. 2004; Hayes et al. 2010; Lucas et al. 2011 ) and for greater efficiency (for a discussion of threshold versus suprathreshold phenotyping methods in genetic association studies, see Genick et al. 2011 ).
Test Stimuli
Five food grade test samples were presented: 219 mM sucrose (Domino), 20 mM gentiobiose (Biosynth), 6.8 mM aspartame (Spectrum), 1.65 mM RebA (Enliten from Corn Products International), and 1 mM RebD (kindly donated by J. Delwiche at PepsiCo). Concentrations of the non-nutritive sweeteners were selected to be above bitterness threshold and have similar sweetness. RebD was near saturation at 1 mM; however, we chose to use a higher concentration of RebA because this was a gene association study. That is, we wanted to maximize bitterness to avoid potential floor effects that might obscure any associations between perceived bitterness and candidate polymorphisms. Sucrose and gentiobiose were included as purely sweet and purely bitter controls. All were prepared using reverse osmosis (RO) water. Test stimuli (10 ml) were presented at room temperature under white light. Stimuli were presented in duplicate in clear plastic medicine cups labeled with a three-digit blinding code. Presentation order was counterbalanced in a blocked Williams Design, with each stimulus being presented once before a duplicate was presented. Participants had a 30-s break enforced between samples, and they rinsed with RO water as needed.
During the main study (Project GIANT-CS), participants sampled (in the same manner as previously described) a 25-mM concentration of AceK (Spectrum), among other stimuli (see Allen et al. 2013; Byrnes and Hayes 2013) . Participants rated sweetness, bitterness, burning/stinging, sourness, savory/umami, and saltiness of the sample on a separate gLMS for each quality. AceK ratings from the participants who completed the follow-up study (n=122) were reanalyzed here to facilitate direct comparisons across stimuli within a single group of individuals. Because of participant overlap, these data should not be taken as independent replication of our prior report . Although the total number of attributes rated differed across sessions, sweet and bitter, the primary attributes of interest, were assessed in each session.
Genetic Analysis
As reported elsewhere , DNA was collected using Oragene saliva collection kits according to the manufacturer's instructions (Genotek Inc., Kanata, Ontario, Canada). Genotypes for selected SNPs in TAS2R4 and TAS2R38 on chromosome 7 and TAS2R9 and TAS2R31 on chromosome 12 were determined using Sequenom MassARRAY technology (Sequenom, San Diego, CA, USA). Primers were acquired from Integrated DNA Technologies (Coralville, IA, USA).
Genotypes were assigned automatically via MassARRAY software (Sequenom) and inspected by two technicians. Fifteen percent of the samples are randomly selected and subjected to a secondary analysis to ensure accuracy.
A tag SNP approach was used due our inability to obtain functional primers for the Arg35Trp (rs10845295) allele in TAS2R31. Repeated attempts were made on multiple platforms (Sequenom MassARRAY and custom TaqMan assays) and these attempts all failed vendor quality control standards, requiring us to use rs10772423 as a tag SNP instead.
Statistical Analysis
Analyses were performed using SAS 9.2 (Cary, NC, USA). SNP analyses were performed individually using analysis of variance (ANOVA) via proc mixed. Post hoc comparisons were made via the Tukey-Kramer method.
Results
Comparing Sweetness and Bitterness Ratings of Sweeteners
Many non-nutritive sweeteners elicit both sweetness and bitterness (DuBois et al. 1991; Hellfritsch et al. 2012; Kamerud and Delwiche 2007; Schiffman et al. 1995b) . Of these reports, many compare sweetness and bitterness to a fixed concentration of reference stimuli. However, use of a fixed modulus (reference stimulus) may minimize real individual differences across people; thus, we used a generalized scale (i.e., a gLMS) here to better reflect differences across individuals, similar to work by Kamerud and Delwiche (2007) . Here, we measure the variation in sweetness and bitterness of RebA and RebD at suprathreshold concentrations, using a gLMS (without using reference samples) (Fig. 1) . By plotting the sweetness of RebA and RebD simultaneously, we observed substantial variation in the perceptual sweetness intensity (Fig. 1a) . Reported sweetness of RebA ranges from 0 to 41.25 and RebD sweetness ranges from 1 to 75. Figure 1b shows the variation in bitterness ratings of RebA and RebD, with bitterness of RebA ranging from 1.5 to 77.25, while RebD ranges from 0 to 20 on a gLMS. Here, we document the wide range of individual variation in RebA and RebD sweetness and bitterness in a large genetically informed cohort.
To allow comparison across non-nutritive sweeteners, AceK ratings from the same individuals (n=122) from day 1 of the main study are also shown here (gray box in Fig. 2) . In ANOVA comparing the non-nutritive sweeteners (i.e., excluding the disaccharides sucrose and gentiobiose), mean bitterness differed across stimuli [F(3,363)=37.20; p<0.0001]. Bitterness from RebA (9.9± 0.8 SEM) was greater than AceK (5.4±0.9), RebD (2.1±0.4), and aspartame (1.1±0.2; all Tukey p's<0.0001). AceK was more bitter than RebD (p=0.002) and aspartame (p<0.0001). There was not sufficient evidence to conclude that RebD was more bitter than aspartame (p=0.70). Figure 2 also shows gentiobiose, a natural disaccharide containing a β-(1-6) linkage, was predominantly bitter with little to no sweetness, while the reverse was true for sucrose, as expected.
The mean sweetness for the four non-nutritive sweeteners fell between moderate and strong on a gLMS. In ANOVA, the sweetness ratings differed across stimuli [F(3,363)=4.53; p=0.004], and this effect was driven by the ratings for aspartame (30.2±1.6 SEM), which was sweeter than RebA, RebD, and AceK (all p's<0.05). Notably, the sweetness of AceK, RebA, and RebD (24.7±1.68, 23.1±1.2, and 24.8 ± 1.36, respectively) were not statistically different from one another (all p's>0.8), which is notable given that they did differ with regard to bitterness. Figure 3 shows the correlations for the bitterness of RebA with the bitterness of RebD, AceK, and aspartame. The bitterness of RebA and RebD were significantly correlated with each other (R 2 =0.33; p<0.0001). Notably, RebA bitterness is not significantly correlated with the bitterness of AceK (R 2 =0.03; p=0.055). Although the association between RebA and aspartame was significant, the amount of variance explained was low (R 2 =0.08; p<0.0013).
TAS2R9 SNP Explains AceK Bitterness but not Bitterness of RebA and RebD
Previously, bitterness ratings of AceK collected from day 1 were associated with an SNP in TAS2R9 (Val187Ala, rs374184; chromosome 12). Here, to allow direct comparisons for these same polymorphisms across different non-nutritive sweeteners, we have reanalyzed the AceK ratings taken from day 1 for the 122 individuals reported here. Because of participant overlap, these data should not be taken as an independent replication of our prior report ; they are included here to facilitate comparisons with RebA and RebD. Figure 4 shows the sweet and bitter ratings for AceK, RebA, and RebD as a function of the Val187Ala SNP in TAS2R9. Here, a primarily European mixed ancestry cohort contained 44 Ala homozygotes, 59 heterozygotes, and 13 Val homozygotes (genotype frequencies did not vary from HardyWeinberg equilibrium χ 2 =1.06; p=0.30). The bitterness from AceK was predicted by the amino acid at position 187, with Val homozygotes and heterozygotes perceiving significantly more bitterness than Ala homozygotes (7.88±2.6, 7.38±1.2, and 1.70±1.4, respectively) [F(2,113)=5.10; p=0.0076]. There was no significant difference between Val homozygotes and heterozygotes (Tukey p=0.98). Ala homozygotes had lower mean bitterness compared to heterozygotes (Tukey p=0.009), and a similar trend was observed between Ala homozygotes and Val homozygotes (p=0.10). AceK sweetness did not differ by Val187Ala genotype [F(2,113)=0.91; p=0.40] .
In this cohort, the bitterness of RebA and RebD were not explained by the Val187Ala allele. RebA bitterness did not differ across genotypes, with Val homozygotes rating 13.9±2.5, heterozygotes 9.6±1.2, and Ala homozygotes 
TAS2R31 SNPs Explain AceK Bitterness but not Bitterness of RebA and RebD
Polymorphisms in TAS2R31 (chromosome 12) have been shown to mediate the bitterness response to sulfonyl amide sweeteners Pronin et al. 2007; Roudnitzky et al. 2011 ). Figure 5 shows the bitterness ratings of RebA, RebD, and AceK across Val240Ile genotypes. Here, Val240Ile (rs10772423) failed to explain the variation in the bitterness of RebA [F(2,113)=1.49; p=0.23]. Similarly, Val240Ile did not explain the variation in RebD bitterness [F(2,113)=0.12; p = 0.89], which was quite low (1.9 ± 0.9, 1.8 ± 0.5, and 2.2±0.6 for Ile homozygotes, heterozygotes, and Val homozygotes, respectively). AceK ratings from day 1 were included to make the point that Val240Ile genotypes explained the bitterness of AceK in these same individuals [F(2,113)=5.33; p=0.006]. Ile homozygotes (n=19) and heterozygotes (n=52) perceived greater bitterness compared to the nonfunctioning, Val homozygotes (n=45) (genotype frequencies did not vary from Hardy-Weinberg equilibrium χ 2 =0.141; p=0.71). Conversely, AceK sweetness ratings did not differ across genotype [F(2,113)=0.52; p=0.60].
1
TAS2R4 SNP does not Explain Bitterness of RebA and RebD
Previously, RebA was shown to activate hT2R4 in vitro (Hellfritsch et al. 2012) . A polymorphism (rs2234001) in TAS2R4 (chromosome 7), which reportedly explains some variation in coffee bitterness (Hayes et al. 2011) , was tested here to determine if this SNP can explain variable bitterness from RebA. The Val96Leu allele in TAS2R4 failed to explain the variation in the bitterness of RebA [F(2,107)= 1.79; p=0.17] nor RebD bitterness [F(2,107)=0.38; p=0.68].
Discussion
Although the main function of non-nutritive sweeteners is to provide sweetness with negligible calories, they often elicit undesirable bitter and metallic sensations (DuBois et al. 1991; Ellis 1995; Helgren et al. 1955) , limiting their utility. Moreover, many non-nutritive sweeteners are synthetic, which are less desirable to many consumers, resulting in greater interest in natural non-nutritive sweeteners like Stevia and monk fruit extracts. Currently, purified RebA extract (from the leaves of S. rebaudiana) is approved for use in foods in the USA as a GRAS ingredient. However, other glycosides within Stevia also elicit a wide range of sweet and bitter sensations (Hellfritsch et al. 2012) . Hellfritsch et al. (2012) recently described sweetness and bitterness response functions for nine different Stevia glycosides. To generate these response curves, individuals were trained using sweet and bitter references (sucralose and rubusoside) at fixed concentrations. Their data suggested that RebD might be a superior sweetener to RebA, as it has a steeper sweetness response curve with lower bitterness compared to RebA. Here, we confirm these data using a different psychophysical approach 1 Previously, we reported a second SNP on TAS2R31, Ala227Val (rs10845293), also associated with the bitterness of AceK in a European-American cohort (i.e., measuring individual perceived intensities without providing a standard reference). We did not generate a doseresponse function; rather, a concentration was selected to provide at least moderate sweetness on a gLMS as well as some bitterness. At isosweet concentrations, RebD elicited significantly less bitterness than RebA. However, we should note that, because the concentrations of RebA and RebD in our study differed, it remains possible that, when tested at the same concentration (rather than equivalent sweetness), RebA may not be significantly more bitter than RebD. Still, our data, coupled with that of Hellfritsch et al. (2012) , suggest that it may be desirable to commercialize RebD as a GRAS ingredient or to selectively breed for Stevia plants with higher RebD content.
Many non-nutritive sweeteners exhibit a hyperbolic doseresponse function, which limits their maximal sweetness. This is why we use the phrase non-nutritive sweeteners rather than "high-intensity sweeteners"; the latter is misleading, given the linear dose-response function for bulk monosaccharides and disaccharides (DuBois et al. 1991; Hayes 2008) . At the concentration used here for RebA (1.65 mM), we are in the flat region of the sweetness response curve (DuBois et al. 1991) . Conversely, the bitterness response curve for RebA continues to increase linearly. That is, it may be possible to use a lower dose and still achieve the desired level of sweetness with lower levels of bitterness. However, because we were specifically interested in the covariation of bitterness across sweeteners, we intentionally selected concentrations that would ensure that participants perceived some bitterness. Overall, aspartame bitterness was very low, consistent with previous reports (DuBois et al. 1991; Kamerud and Delwiche 2007) . Roudnitzky et al. (2011) showed that AceK bitterness recognition thresholds are associated with polymorphisms in TAS2R31. Subsequently, we extended this work using a tag SNP approach, showing that TAS2R31 polymorphisms could also explain the variation in the suprathreshold bitterness of AceK . Here, we show that a tag SNP thought to be in linkage disequilibrium with the functional Arg35Trp allele in TAS2R31 does not explain variability in the Fig. 4 , except for the Val240Ile polymorphism in TAS2R31. AceK bitterness ratings were significantly different across genotype, as expected, while there was no evidence of an effect for RebA and RebD (see text) Fig. 4 Effect of the TAS2R9 Val187Ala polymorphism on the bitterness of AceK, RebA, and RebD. As expected, the bitterness of AceK (collected on a separate day) was significantly different across genotype for these individuals; conversely, no effect of genotype was observed for RebA or RebD (see text) Fig. 3 Correlations of bitterness ratings between RebA and RebD, AceK, and aspartame bitterness perception of RebA or RebD. While the activation of TAS2R31 with AceK has been well documented (Kuhn et al. 2004; Meyerhof et al. 2010; Roudnitzky et al. 2011) , we are unaware of any reports showing that RebA and RebD activate TAS2R31 in vitro or in vivo. Likewise, putatively functional polymorphisms in TAS2R9 did not predict the bitterness of RebA or RebD. The inability of TAS2R31 and TAS2R9 SNPs to predict RebA and RebD bitterness would be expected given the absence of a relationship between AceK bitterness and RebA/RebD bitterness. It is likely that the bitterness from RebA and RebD in vivo occur via other bitter taste receptors, such as hT2R4 and hT2R14 (Hellfritsch et al. 2012) . Additional work is needed to determine if allelic variations alter the function of hT2R14, and thus, might explain variable bitterness from RebA and RebD. Here, we tested one putatively functional SNP in TAS2R4 and did not find any evidence of a relationship; however, full sequencing of this gene would be required to rule out an effect of TAS2R4 SNPs on RebA bitterness. Future work should explore potential relationships between additional TAS2R4 and TAS2R14 polymorphisms in relation to steviol glycoside recognition thresholds and suprathreshold bitterness.
Conclusions
Here, we show that steviol glycoside extracts from Stevia differ in their bitterness at suprathreshold concentrations that are isosweet. Purified RebD may be a superior natural nonnutritive sweetener compared to RebA, as it elicits less bitterness than RebA. Functional SNPs in TAS2R31 known to explain variation in AceK and saccharin bitterness were unable to explain the variability in the bitterness of RebA or RebD. This is consistent with psychophysical data showing that AceK bitterness was not correlated with the bitterness of RebA or RebD. However, we also note that AceK data were collected in a separate testing context on a different day, which may have attenuated our ability to observe a potential relationship. Nonetheless, taken together, the psychophysical data and genetic data both suggest the absence of a relationship between AceK bitterness and RebA and RebD bitterness. Collectively, these data are consistent with our position that bitterness is not a simple monolithic trait that is high or low in an individual (Hayes et al. , 2011 . Practically, this suggests that consumers who report aversive sensations from RebA and RebD may not report aversive sensations from AceK and vice versa. Whether variable bitterness in Stevia extracts can be explained by polymorphisms in other bitter taste genes (TAS2Rs) remains to be determined.
